The impact of the ACE2 rs2074192 gene polymorphism on cytokine production (IL-1β, IL-6, IL-8, and TNF-α) is also significant and should be considered when implementing renin-angiotensin-aldosterone system targeting drugs in COVID-19 therapy (9, 75, 76). This evidence concerns the gene ACE2 and COVID-19.